Abstract
Objective:
To evaluate the efficacy of the addition to milk, 5 min and 10 h before its consumption, of a lactase obtained from Kluyveromyces lactis in lactose malabsorbers with intolerance.
Design:
Double-blind, placebo-controlled, crossover study.
Setting:
University Hospital.
Subjects:
In total, 11 male and 19 female (aged from 18 to 65 y, mean age 43.3 y) lactose malabsorbers with intolerance participated.
Interventions:
Each patient underwent three H2 breath tests, in a random order. We used 400 ml of cow's semiskimmed milk as substrate and a β-galactosidase obtained from K. lactis. The test A was carried out adding to the milk the enzyme (3000 UI), 10 h before its consumption; the test B was performed adding the β-galactosidase (6000 UI) 5 min before milk ingestion and the test C was made using placebo. We evaluated the maximum breath H2 concentration, the cumulative H2 excretion and a clinical score based on intolerance symptoms (bloating, abdominal pain, flatulence and diarrhoea).
Results:
Our study showed a significant reduction of the mean maximum H2 concentration after both test A (12.07±7.8 p.p.m.) and test B (13.97±7.99 p.p.m.) compared with test C (51.46±16.12 p.p.m.) (ANOVA F=54.33, P<0.001). Similarly, there was a significant reduction of the mean cumulative H2 excretion after both test A (1428±1156 p.p.m.) and test B (1761±966 p.p.m.) compared with test C (5795±2707 p.p.m.) (ANOVA F=31.46, P<0.001). We also observed a significant reduction of the mean clinical score after both test A (0.36±0.55) and test B (0.96±0.85) compared with test C (3.7±0.79) (ANOVA F=106.81, P<0.001). Moreover, with regard to the mean clinical score, there was a significant reduction after test A with respect to test B (Bonferroni's P=0.03).
Conclusions:
Our study shows that in lactose malabsorbers with intolerance, the lactase obtained from K. lactis can represent a valid therapeutic strategy, with objective and subjective efficacy and without side effects.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Barillas C & Solomons NW (1987): Effective reduction of lactose maldigestion in preschool children by direct addition of b-galactosidase to milk at mealtime. Pediatrics 79, 766–772.
Briet F, Pochart P, Marteau P, Flourie B, Arrigoni E & Rambaud JC (1997): Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect? Gut 41, 632–635.
Corazza GR, Benati G, Sorge M, Strocchi A, Calza G & Gasbarrini G (1992): Beta-galactosidase from Aspergillus niger in adult lactose malabsorption: a double-blind crossover study. Aliment. Pharmacol. Ther. 6, 61–66.
Di Stefano M, Veneto G, Malservisi S, Cecchetti L, Minguzzi L, Strocchi A & Corazza GR (2002): Lactose malabsorption and intolerance and peak bone mass. Gastroenterology 122, 1793–1799.
Gilat T, Russo S, Gelman-Malachi E & Aldor TA (1972): Lactase in man: a non-adaptable enzyme. Gastroenterology 62, 1125–1127.
Gudmand-Hoyer E (1994): The clinical significance of disaccharide maldigestion. Am. J. Clin. Nutr. 59, 735S–741S.
Kotler DP, Holt PR & Rosensweig NS (1982): Modification of the breath hydrogen test increased sensitivity for the detection of carbohydrate malabsorption. Lab. Clin. Med. 100, 798–805.
Lami F, Callegari C, Tatali M, Graziano L, Guidetti C, Miglioli M & Barbara L (1988): Efficacy of addition of exogenous lactase to milk in adult lactase deficiency. Am. J. Gastroenterol. 83, 1145–1149.
Lin MY, Dipalma JA, Martini MC, Gross CJ, Harlander SK & Savaiano DA (1993): Comparative effects of exogenous lactase (beta-galactosidase) preparations on in vivo lactose digestion. Dig. Dis. Sci. 38, 2022–2027.
Onwulata CI, Rao DR & Vankineni P (1989): Relative efficiency of yogurt, sweet acidophilus milk, hydrolyzed-lactose milk, and a commercial lactase tablet in alleviating lactose maldigestion. Am. J. Clin. Nutr. 49, 1233–1237.
Peuhkuri K, Vapaatalo H, Nevala R & Korpela R (1999): Influence of the pharmacological modification of gastric emptying on lactose digestion and gastrointestinal symptoms. Aliment. Pharmacol. Ther. 13, 81–86.
Rask Pedersen E, Jensen BH, Jensen HJ, Keldsbo IL, Hylander Moller E & Norby Rasmussen S (1982): Lactose malabsorption and tolerance of lactose-hydrolyzed milk. A double-blind controlled crossover study. Scand. J. Gastroenterol. 17, 861–864.
Rosado JL, Solomons NW, Lisker R, Bourges H, Anrubio G, Garcia A, Perez-Briceno R & Aizupuru E (1984): Enzyme replacement therapy for primary adult lactase deficiency. Gastroenterology 87, 1072–1082.
Saltzman JR, Russell RM, Golner B, Barakat S, Dallal GE & Goldin BR (1999): A randomized trial of Lactobacillus acidophilus BG2FO4 to treat lactose intolerance. Am. J. Clin. Nutr. 69, 140–146.
Shaw AD & Davies GJ (1999): Lactose intolerance: problems in diagnosis and treatment. J. Clin. Gastroenterol. 28, 208–216.
Solomons NW, Guerrero AM & Torun B (1985a): Dietary manipulation of the postprandial colonic lactose fermentation: II. Addition of exogenous microbial beta-galactosidase at mealtime. Am. J. Clin. Nutr. 41, 209–221.
Solomons NW, Guerrero AM & Torun B (1985b): Effective in vivo hydrolysis of milk lactose by beta-galactosidase in the presence of solid foods. Am. J. Clin. Nutr. 41, 222–227.
Suarez FL, Savaiano DA & Levitt MD (1995): The treatment of lactose intolerance. Aliment. Pharmacol. Ther. 9, 589–597.
Szilagyi A (2002): Lactose: a potential prebiotic. Aliment. Pharmacol. Ther. 16, 1591–1602.
Szilagyi A, Salomon R & Seidman E (1996): Influence of loperamide on lactose handling and oral-coecal transit time. Aliment. Pharmacol. Ther. 10, 765–770.
Szilagyi A, Torchinsky A & Calacone A (2000): Possible therapeutic use of loperamide for symptoms of lactose intolerance. Can. J. Gastroenterol. 14, 581–587.
Swagerty DL, Walling AD & Klein RM (2002): Lactose intolerance. Am. Fam. Physician 65, 1845–1850.
Wang Y, Harvey CB, Hollox EJ, Phillips AD, Poulter M, Clay P, Walker-Smith JA & Swallow DM (1998): The genetically programmed down-regulation of lactase in children. Gastroenterology 114, 1230–1236.
Author information
Authors and Affiliations
Corresponding author
Additional information
Guarantor: M Montalto.
Contributors: MM designed the study, wrote the manuscript and recruited the patients with the help of GN. LS, VC, MV, LC, RM, AG and GG participated in clinical assessment, data management and editing of the paper. MC carried out statistical calculations. All authors reviewed the manuscript and approved the final version.
Rights and permissions
About this article
Cite this article
Montalto, M., Nucera, G., Santoro, L. et al. Effect of exogenous β-galactosidase in patients with lactose malabsorption and intolerance: a crossover double-blind placebo-controlled study. Eur J Clin Nutr 59, 489–493 (2005). https://doi.org/10.1038/sj.ejcn.1602098
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejcn.1602098
Keywords
This article is cited by
-
In Vitro Assessment of Probiotic Potential of Saccharomyces Cerevisiae DABRP5 Isolated from Bollo Batter, a Traditional Goan Fermented Food
Probiotics and Antimicrobial Proteins (2021)
-
Lactose Intolerance—Old and New Knowledge on Pathophysiological Mechanisms, Diagnosis, and Treatment
SN Comprehensive Clinical Medicine (2021)
-
The effects of the DDS-1 strain of lactobacillus on symptomatic relief for lactose intolerance - a randomized, double-blind, placebo-controlled, crossover clinical trial
Nutrition Journal (2015)